{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:32:46Z","timestamp":1773693166343,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T00:00:00Z","timestamp":1467072000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1245\/s10434-016-5361-6","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T19:58:18Z","timestamp":1467143898000},"page":"3736-3743","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location"],"prefix":"10.1245","volume":"23","author":[{"given":"Kazunari","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios A.","family":"Margonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhree","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Buettner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Andreatos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiz","family":"Gani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neda","family":"Amini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaya","family":"Spolverato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Pawlik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,28]]},"reference":[{"key":"5361_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"5361_CR2","doi-asserted-by":"crossref","first-page":"744-52","DOI":"10.1016\/j.jamcollsurg.2009.12.040","volume":"210","author":"MG House","year":"2010","unstructured":"House MG, Ito H, Gonen M, et al. Survival after hepatic resection for metastatic colorectal cancer: trends in outcomes for 1,600 patients during two decades at a single institution. J Am Coll Surg. 2010;210:744-52\u2013752-45.","journal-title":"J Am Coll Surg"},{"key":"5361_CR3","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1200\/JCO.2008.20.5278","volume":"27","author":"S Kopetz","year":"2009","unstructured":"Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27:3677\u201383.","journal-title":"J Clin Oncol"},{"key":"5361_CR4","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","volume":"369","author":"JY Douillard","year":"2013","unstructured":"Douillard JY, Oliner KS, Siena S, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer. N Engl J Med. 2013;369:1023\u201334.","journal-title":"N Engl J Med"},{"key":"5361_CR5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1200\/JCO.2014.59.7633","volume":"33","author":"MG Fakih","year":"2015","unstructured":"Fakih MG. Metastatic colorectal cancer: current state and future directions. J Clin Oncol. 2015;33:1809\u201324.","journal-title":"J Clin Oncol"},{"key":"5361_CR6","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/gut.2008.159137","volume":"58","author":"R Seth","year":"2009","unstructured":"Seth R, Crook S, Ibrahem S, Fadhil W, Jackson D, Ilyas M. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras\/Raf signalling pathway in advanced colorectal cancer. Gut. 2009;58:1234\u201341.","journal-title":"Gut"},{"key":"5361_CR7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/bjs.9870","volume":"102","author":"KW Brudvik","year":"2015","unstructured":"Brudvik KW, Kopetz SE, Li L, Conrad C, Aloia TA, Vauthey JN. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. Br J Surg. 2015;102:1175\u201383.","journal-title":"Br J Surg"},{"key":"5361_CR8","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1002\/cncr.28954","volume":"120","author":"NE Kemeny","year":"2014","unstructured":"Kemeny NE, Chou JF, Capanu M, et al. KRAS mutation influences recurrence patterns in patients undergoing hepatic resection of colorectal metastases. Cancer. 2014;120:3965\u201371.","journal-title":"Cancer"},{"key":"5361_CR9","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1245\/s10434-015-4587-z","volume":"22","author":"GA Margonis","year":"2015","unstructured":"Margonis GA, Spolverato G, Kim Y, Karagkounis G, Choti MA, Pawlik TM. Effect of KRAS mutation on long-term outcomes of patients undergoing hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2015;22:4158\u201365.","journal-title":"Ann Surg Oncol"},{"key":"5361_CR10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/SLA.0b013e3182a5025a","volume":"258","author":"JN Vauthey","year":"2013","unstructured":"Vauthey JN, Zimmitti G, Kopetz SE, et al. RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases. Ann Surg. 2013;258:619\u201326.","journal-title":"Ann Surg"},{"key":"5361_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/ejso.2000.1029","volume":"27","author":"H Petrowsky","year":"2001","unstructured":"Petrowsky H, Sturm I, Graubitz O, et al. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases. Eur J Surg Oncol. 2001;27:80\u20137.","journal-title":"Eur J Surg Oncol"},{"key":"5361_CR12","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1002\/cncr.27666","volume":"118","author":"JS Rose","year":"2012","unstructured":"Rose JS, Serna DS, Martin LK, et al. Influence of KRAS mutation status in metachronous and synchronous metastatic colorectal adenocarcinoma. Cancer. 2012;118:6243\u201352.","journal-title":"Cancer"},{"key":"5361_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jso.23063","volume":"106","author":"HW Teng","year":"2012","unstructured":"Teng HW, Huang YC, Lin JK, et al. BRAF mutation is a prognostic biomarker for colorectal liver metastasectomy. J Surg Oncol. 2012;106:123\u20139.","journal-title":"J Surg Oncol"},{"key":"5361_CR14","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1111\/j.1572-0241.2000.02327.x","volume":"95","author":"WA Bleeker","year":"2000","unstructured":"Bleeker WA, Hayes VM, Karrenbeld A, et al. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes\u2019 C colon cancer. Am J Gastroenterol. 2000;95:2953\u20137.","journal-title":"Am J Gastroenterol"},{"key":"5361_CR15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ejca.2015.03.015","volume":"51","author":"SY Brule","year":"2015","unstructured":"Brule SY, Jonker DJ, Karapetis CS, et al. Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17. Eur J Cancer. 2015;51:1405\u201314.","journal-title":"Eur J Cancer"},{"key":"5361_CR16","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","volume":"113","author":"JA Bufill","year":"1990","unstructured":"Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990;113:779\u201388.","journal-title":"Ann Intern Med"},{"key":"5361_CR17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejso.2014.11.001","volume":"41","author":"GH Lee","year":"2015","unstructured":"Lee GH, Malietzis G, Askari A, Bernardo D, Al-Hassi HO, Clark SK. Is right-sided colon cancer different to left-sided colorectal cancer? A systematic review. Eur J Surg Oncol. 2015;41:300\u20138.","journal-title":"Eur J Surg Oncol"},{"key":"5361_CR18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1440-1746.2007.04923.x","volume":"23","author":"T Nawa","year":"2008","unstructured":"Nawa T, Kato J, Kawamoto H, et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol. 2008;23:418\u201323.","journal-title":"J Gastroenterol Hepatol"},{"key":"5361_CR19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000443644","volume":"33","author":"U Nitsche","year":"2016","unstructured":"Nitsche U, Stogbauer F, Spath C, et al. Right sided colon cancer as a distinct histopathological subtype with reduced prognosis. Dig Surg. 2016;33:157\u201363.","journal-title":"Dig Surg"},{"key":"5361_CR20","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/annonc\/mdu275","volume":"25","author":"E Missiaglia","year":"2014","unstructured":"Missiaglia E, Jacobs B, D\u2019Ario G, et al. Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features. Ann Oncol. 2014;25:1995\u20132001.","journal-title":"Ann Oncol"},{"key":"5361_CR21","unstructured":"Heinemann V, Modest DP, Fischer von Weikersthal L, et al., editors. Gender and tumor location as predictors for efficacy: influence on endpoints in first-line treatment with FOLFIRI in combination with cetuximab or bevacizumab in the AIO KRK 0306 (FIRE3) trial. Paper presented at: ASCO Annual Meeting, 2014."},{"key":"5361_CR22","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00432-014-1678-3","volume":"140","author":"JC Einem von","year":"2014","unstructured":"von Einem JC, Heinemann V, von Weikersthal LF, et al. Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12\/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial. J Cancer Res Clin Oncol. 2014;140:1607\u201314.","journal-title":"J Cancer Res Clin Oncol"},{"key":"5361_CR23","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/1471-2407-13-439","volume":"13","author":"V Popovici","year":"2013","unstructured":"Popovici V, Budinska E, Bosman FT, Tejpar S, Roth AD, Delorenzi M. Context-dependent interpretation of the prognostic value of BRAF and KRAS mutations in colorectal cancer. BMC Cancer. 2013;13:439.","journal-title":"BMC Cancer"},{"key":"5361_CR24","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.3748\/wjg.v21.i21.6470","volume":"21","author":"H Shen","year":"2015","unstructured":"Shen H, Yang J, Huang Q, et al. Different treatment strategies and molecular features between right-sided and left-sided colon cancers. World J Gastroenterol. 2015;21:6470\u20138.","journal-title":"World J Gastroenterol"},{"key":"5361_CR25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00534-012-0531-9","volume":"20","author":"Y Umeda","year":"2013","unstructured":"Umeda Y, Nagasaka T, Mori Y, et al. Poor prognosis of KRAS or BRAF mutant colorectal liver metastasis without microsatellite instability. J Hepatobiliary Pancreat Sci. 2013;20:223\u201333.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"5361_CR26","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","volume":"360","author":"E Cutsem Van","year":"2009","unstructured":"Van Cutsem E, Kohne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009;360:1408\u201317.","journal-title":"N Engl J Med"},{"key":"5361_CR27","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1200\/JCO.2010.33.5091","volume":"29","author":"E Cutsem Van","year":"2011","unstructured":"Van Cutsem E, Kohne CH, Lang I, et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol. 2011;29:2011\u20139.","journal-title":"J Clin Oncol"},{"key":"5361_CR28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00000658-199909000-00004","volume":"230","author":"Y Fong","year":"1999","unstructured":"Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309\u201318.","journal-title":"Ann Surg"},{"key":"5361_CR29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/tpj.2014.73","volume":"15","author":"MK Maus","year":"2015","unstructured":"Maus MK, Hanna DL, Stephens CL, et al. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy. Pharmacogenomics J. 2015;15:354\u201362.","journal-title":"Pharmacogenomics J"},{"key":"5361_CR30","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/gast.2002.32997","volume":"122","author":"N Hawkins","year":"2002","unstructured":"Hawkins N, Norrie M, Cheong K, et al. CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology. 2002;122:1376\u201387.","journal-title":"Gastroenterology."},{"key":"5361_CR31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/gut.51.6.797","volume":"51","author":"M Rijnsoever van","year":"2002","unstructured":"van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, Iacopetta B. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut. 2002;51:797\u2013802.","journal-title":"Gut."},{"key":"5361_CR32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1245\/ASO.2004.03.585","volume":"11","author":"R Haddad","year":"2004","unstructured":"Haddad R, Ogilvie RT, Croitoru M, et al. Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases. Ann Surg Oncol. 2004;11:977\u201382.","journal-title":"Ann Surg Oncol."},{"key":"5361_CR33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6604867","volume":"100","author":"M Koopman","year":"2009","unstructured":"Koopman M, Kortman GA, Mekenkamp L, et al. Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. Br J Cancer. 2009;100:266\u201373.","journal-title":"Br J Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5361-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-016-5361-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5361-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:21:48Z","timestamp":1498324908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-016-5361-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,28]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["5361"],"URL":"https:\/\/doi.org\/10.1245\/s10434-016-5361-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,28]]}}}